UBV
ATYR

United Bank (Virginia)’s aTyr Pharma ATYR Stock Holding History

United Bank (Virginia)’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,970
Closed -$8.64K – 130
2025
Q3 		$8.64K Sell
11,970
-4,860
-29% -$22K ﹤0.01% 128
2025
Q2 		$85.3K Buy
16,830
+3,000
+22% +$11.8K 0.01% 136
2025
Q1 		$41.8K Buy
+13,830
New +$50.4K 0.01% 135

Other funds holding ATYR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

United Bank (Virginia)'s ATYR Position: Q4 2025 in Review

United Bank (Virginia) sold out of aTyr Pharma (ATYR) in Q4 2025, closing a stake of 11,970 shares — an estimated $8.64K sold.

United Bank (Virginia) first reported a position in ATYR in Q1 2025 and held it in 3 quarters. The position peaked at $85.3K in Q2 2025. 84 funds tracked by Wall St. Rank hold ATYR as of Q4 2025.

  • United Bank (Virginia) reported no remaining aTyr Pharma position as of Q4 2025 after selling out during the quarter.
  • United Bank (Virginia) sold 11,970 aTyr Pharma shares in Q4 2025, an estimated $8.64K.
  • United Bank (Virginia) first reported a position in aTyr Pharma in Q1 2025 and held it in 3 quarters.
  • United Bank (Virginia)'s aTyr Pharma position peaked at $85.3K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2025.

Based on United Bank (Virginia)'s 13F filing for Q4 2025, filed 13 Feb 2026.